Renal effects of FK453: A potent non‐xanthine adenosine A1 receptor antagonist
- 1 September 1995
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 36 (1) , 25-34
- https://doi.org/10.1002/ddr.430360105
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Diuretic Effects of KW-3902 (8-(Noradamantan-3-yl)-1,3-dipropylxanthine), a Novel Adenosine A1 Receptor Antagonist, in Conscious Dogs.Biological & Pharmaceutical Bulletin, 1993
- Diuretic and saliuretic effects of 1,3-dipropyl-8-cyclopentylxanthine, a selective A1-adenosine receptor antagonistJournal of Pharmacy and Pharmacology, 1991
- 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressantsJournal of Medicinal Chemistry, 1990
- An in vitro analysis of purine‐mediated renal vasoconstriction in rat isolated kidneyBritish Journal of Pharmacology, 1987
- PD 116,948, a highly selective A1 adenosine receptor antagonistLife Sciences, 1987
- The adenosine receptor antagonist, 8-phenyltheophylline, causes diuresis and saliuresis in the ratJournal of Pharmacy and Pharmacology, 1986
- The role of adenosine in the regulation of glomerular filtration rate and renin secretionTrends in Pharmacological Sciences, 1984
- Renal handling of uric acid in normal and gouty subject: evidence for a 4-component system.Annals of the Rheumatic Diseases, 1980
- The Site of Action of Furosemide and Other Sulfonamide Diuretics in the Dog*Journal of Clinical Investigation, 1965
- A new method for the determination of inulin in plasma and urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1956